124 related articles for article (PubMed ID: 6851403)
1. Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine.
Scriven AJ; Dollery CT; Murphy MB; Macquin I; Brown MJ
Clin Pharmacol Ther; 1983 Jun; 33(6):710-6. PubMed ID: 6851403
[TBL] [Abstract][Full Text] [Related]
2. Changes in blood pressure and plasma catecholamines caused by tyramine and cold exposure.
Scriven AJ; Brown MJ; Murphy MB; Dollery CT
J Cardiovasc Pharmacol; 1984; 6(5):954-60. PubMed ID: 6209506
[TBL] [Abstract][Full Text] [Related]
3. Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine.
Schäfers RF; Poller U; Pönicke K; Geissler M; Daul AE; Michel MC; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):239-49. PubMed ID: 9050018
[TBL] [Abstract][Full Text] [Related]
4. Does regional norepinephrine spillover represent local sympathetic activity?
Chang PC; Kriek E; van der Krogt JA; van Brummelen P
Hypertension; 1991 Jul; 18(1):56-66. PubMed ID: 1860712
[TBL] [Abstract][Full Text] [Related]
5. Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man.
Goldstein DS; Nurnberger J; Simmons S; Gershon ES; Polinsky R; Keiser HR
Life Sci; 1983 Mar; 32(10):1057-63. PubMed ID: 6827888
[TBL] [Abstract][Full Text] [Related]
6. The effect of angiotensin II on haemodynamic and plasma noradrenaline responses to tyramine infusion in man.
Seidelin PH; Struthers AD
Eur J Clin Pharmacol; 1991; 41(2):119-23. PubMed ID: 1743243
[TBL] [Abstract][Full Text] [Related]
7. Effect of tyramine on myocardial catecholamine release in coronary heart disease.
Forman MB; Robertson D; Goldberg M; Bostick D; Uderman H; Perry JM; Robertson RM
Am J Cardiol; 1984 Feb; 53(4):476-80. PubMed ID: 6695776
[TBL] [Abstract][Full Text] [Related]
8. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.
Uehlinger DE; Weidmann P; Gnaedinger MP; Shaw S; Lang RE
J Clin Endocrinol Metab; 1986 Sep; 63(3):669-74. PubMed ID: 2942555
[TBL] [Abstract][Full Text] [Related]
9. Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man.
Mathias CJ; Christensen NJ; Corbett JL; Frankel HL; Spalding JM
Circ Res; 1976 Aug; 39(2):204-8. PubMed ID: 939005
[TBL] [Abstract][Full Text] [Related]
10. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles.
Vincent S; Bieck PR; Garland EM; Loghin C; Bymaster FP; Black BK; Gonzales C; Potter WZ; Robertson D
Circulation; 2004 Jun; 109(25):3202-7. PubMed ID: 15184278
[TBL] [Abstract][Full Text] [Related]
11. Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects.
Bianchetti MG; Minder I; Beretta-Piccoli C; Meier A; Weidmann P
Klin Wochenschr; 1982 May; 60(9):465-70. PubMed ID: 7045511
[TBL] [Abstract][Full Text] [Related]
12. Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans.
Wilson RF; Christensen BV; Olivari MT; Simon A; White CW; Laxson DD
Circulation; 1991 Apr; 83(4):1210-20. PubMed ID: 2013143
[TBL] [Abstract][Full Text] [Related]
13. Influence of atropine on the cardiovascular effects of noradrenaline and tyramine in elder volunteers.
Poller U; Schäfers RF; Schmuck S; Jakubetz J; Radke J; Daul AE; Pönicke K; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):100-6. PubMed ID: 9228196
[TBL] [Abstract][Full Text] [Related]
14. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration.
Jacob G; Costa F; Vincent S; Robertson D; Biaggioni I
Circulation; 2003 May; 107(19):2475-9. PubMed ID: 12707242
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic blockade decreases norepinephrine release in humans.
Rosen SG; Supiano MA; Perry TJ; Linares OA; Hogikyan RV; Smith MJ; Halter JB
Am J Physiol; 1990 Jun; 258(6 Pt 1):E999-1005. PubMed ID: 2163203
[TBL] [Abstract][Full Text] [Related]
16. Dietary sodium restriction and pressor responsiveness to tyramine in spontaneously hypertensive rats.
Leenen FH; Klement G; Yuan B
J Hypertens; 1992 Sep; 10(9):929-37. PubMed ID: 1328374
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
Veith RC; Best JD; Halter JB
J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation.
Wilson RF; Laxson DD; Christensen BV; McGinn AL; Kubo SH
Circulation; 1993 Jul; 88(1):165-71. PubMed ID: 8319329
[TBL] [Abstract][Full Text] [Related]
19. The response of plasma catecholamines to intravenous labetalol: a comparison with sodium nitroprusside.
Lin MS; McNay JL; Shepherd AM; Keeton TK
Clin Pharmacol Ther; 1983 Oct; 34(4):466-73. PubMed ID: 6617068
[TBL] [Abstract][Full Text] [Related]
20. Human galanin reduces plasma norepinephrine levels in man.
degli Uberti EC; Ambrosio MR; Bondanelli M; Trasforini G; Margutti A; Valentini A; Rossi R; Franceschetti P
J Clin Endocrinol Metab; 1995 Jun; 80(6):1894-8. PubMed ID: 7539818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
